MATEON THERAPEUTICS, INC.
Patent Owner
Stats
- 16 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 23, 2018 most recent publication
Details
- 16 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 143 Total Citation Count
- Feb 16, 2000 Earliest Filing
- 3 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
RE45907 Functionalized stilbene derivatives as improved vascular targeting agentsFeb 13, 14Mar 01, 16[A01N, C07F, C07C]
7456214 Chromene-containing compounds with anti-tubulin and vascular targeting activityMay 21, 04Nov 25, 08[A61K]
7384925 Functionalized stilbene derivatives as improved vascular targeting agentsJul 18, 05Jun 10, 08[]
7358236 Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agentsJun 23, 03Apr 15, 08[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
RE45720 Functionalized stilbene derivatives as improved vascular targeting agentsExpiredFeb 13, 14Oct 06, 15[C07F, C07C]
7001926 Tubulin binding agents and corresponding prodrug constructsExpiredApr 01, 03Feb 21, 06[A61K]
6956054 Compositions and methods for use in targeting vascular destructionExpiredAug 14, 02Oct 18, 05[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
